C107H105ClF5N33O13 — CID 162084187
4-amino-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2-ethoxybenzamide;1-(4-chlorophenyl)-3-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]urea;1-(2,6-difluorophenyl)-3-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]urea;1-(2,6-difluorophenyl)-3-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]urea;1-[(4-fluorophenyl)methyl]-3-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]urea (PubChem CID 162084187) has the molecular formula C107H105ClF5N33O13 and a molecular weight of 2191.68 g/mol. Its IUPAC name is 4-amino-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2-ethoxybenzamide;1-(4-chlorophenyl)-3-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]urea;1-(2,6-difluorophenyl)-3-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]urea;1-(2,6-difluorophenyl)-3-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]urea;1-[(4-fluorophenyl)methyl]-3-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]urea.
| Compound Name | 4-amino-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2-ethoxybenzamide;1-(4-chlorophenyl)-3-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]urea;1-(2,6-difluorophenyl)-3-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]urea;1-(2,6-difluorophenyl)-3-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]urea;1-[(4-fluorophenyl)methyl]-3-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]urea |
|---|---|
| PubChem CID | 162084187 |
| Molecular Formula | C107H105ClF5N33O13 |
| Molecular Weight | 2191.68 g/mol |
| Exact Mass | 2189.82 |
| IUPAC Name | 4-amino-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2-ethoxybenzamide;1-(4-chlorophenyl)-3-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]urea;1-(2,6-difluorophenyl)-3-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]urea;1-(2,6-difluorophenyl)-3-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]urea;1-[(4-fluorophenyl)methyl]-3-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]urea |
| SMILES | CCOc1cc(N)ccc1C(=O)Nc1cn[nH]c1-c1nc2cc(OC)c(OC)cc2[nH]1.COc1cc2nc(-c3[nH]ncc3NC(=O)Nc3c(F)cccc3F)[nH]c2cc1OC.O=C(NCc1ccc(F)cc1)Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1.O=C(Nc1ccc(Cl)cc1)Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)Nc1c(F)cccc1F |
| InChI | InChI=1S/C23H24FN7O2.C22H22ClN7O2.C22H21F2N7O2.C21H22N6O4.C19H16F2N6O3/c24-17-4-1-15(2-5-17)12-25-23(32)29-20-13-26-30-21(20)22-27-18-6-3-16(11-19(18)28-22)14-31-7-9-33-10-8-31;23-15-2-4-16(5-3-15)25-22(31)28-19-12-24-29-20(19)21-26-17-6-1-14(11-18(17)27-21)13-30-7-9-32-10-8-30;23-14-2-1-3-15(24)19(14)29-22(32)28-18-11-25-30-20(18)21-26-16-5-4-13(10-17(16)27-21)12-31-6-8-33-9-7-31;1-4-31-16-7-11(22)5-6-12(16)21(28)26-15-10-23-27-19(15)20-24-13-8-17(29-2)18(30-3)9-14(13)25-20;1-29-14-6-11-12(7-15(14)30-2)24-18(23-11)17-13(8-22-27-17)25-19(28)26-16-9(20)4-3-5-10(16)21/h1-6,11,13H,7-10,12,14H2,(H,26,30)(H,27,28)(H2,25,29,32);1-6,11-12H,7-10,13H2,(H,24,29)(H,26,27)(H2,25,28,31);1-5,10-11H,6-9,12H2,(H,25,30)(H,26,27)(H2,28,29,32);5-10H,4,22H2,1-3H3,(H,23,27)(H,24,25)(H,26,28);3-8H,1-2H3,(H,22,27)(H,23,24)(H2,25,26,28) |
| InChIKey | ZCSYQQSTPQHCMI-UHFFFAOYSA-N |
| XLogP | 18.13 |
| TPSA | 590.00 Ų |
| H-Bond Donors | 20 |
| H-Bond Acceptors | 27 |
| Rotatable Bonds | 28 |
| Heavy Atoms | 159 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2191.68 |
| LogP ≤ 5 | 18.13 |
| H-Bond Donors ≤ 5 | 20 |
| H-Bond Acceptors ≤ 10 | 27 |
| Structural Alerts | {'alert_name': 'aniline', 'substructure': 'N/A'} |
|---|